Press releases
- Politan Comments on Masimo’s Latest Entrenchment Maneuvers
- Masimo Files Complaint Seeking Injunction Requiring Politan to Correct Material Misstatements
- Leading Proxy Advisory Firm ISS Recommends Masimo Shareholders Vote FOR Both of Politan’s Director Nominees
- Masimo Responds to Politan’s Continuing Misrepresentations
- Leading Proxy Advisory Firm Glass Lewis Recommends Masimo Shareholders Vote FOR Both of Politan’s Director Nominees
- Masimo Independent Director Michelle Brennan Encourages Shareholders to Support an Urgently Needed Cultural Reset in the Company’s Boardroom
- Masimo Exposes Politan’s Governance Hypocrisy
- Masimo Announces Preliminary Second Quarter 2024 Revenue and Select Financial Results
- Masimo Provides Facts, Exposes False Narratives in Response to Latest Politan Fictions
- Masimo Nominee Christopher Chavez Would Bring Fierce Independence, Exemplary Medtech CEO Experience to Masimo Board
More ▼
Key statistics
As of last trade, Masimo Corp (3M4:FRA) traded at 97.28, 35.68% above the 52 week low of 71.70 set on Nov 08, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 97.28 |
---|---|
High | 97.28 |
Low | 97.28 |
Bid | 97.32 |
Offer | 99.08 |
Previous close | 97.56 |
Average volume | 145.14 |
---|---|
Shares outstanding | 53.18m |
Free float | 49.05m |
P/E (TTM) | 74.43 |
Market cap | 5.80bn USD |
EPS (TTM) | 1.46 USD |
Data delayed at least 15 minutes, as of Jul 22 2024 08:22 BST.
More ▼